AU6832394A - Stable quinolone and naphthyridine premix formulations - Google Patents

Stable quinolone and naphthyridine premix formulations

Info

Publication number
AU6832394A
AU6832394A AU68323/94A AU6832394A AU6832394A AU 6832394 A AU6832394 A AU 6832394A AU 68323/94 A AU68323/94 A AU 68323/94A AU 6832394 A AU6832394 A AU 6832394A AU 6832394 A AU6832394 A AU 6832394A
Authority
AU
Australia
Prior art keywords
quinolone
naphthyridine
stable
premix formulations
premix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68323/94A
Inventor
Laman A. Al-Razzak
Nishith V Gandhi
Pramod K. Gupta
Patricia L Ludwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU6832394A publication Critical patent/AU6832394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU68323/94A 1993-05-15 1994-05-13 Stable quinolone and naphthyridine premix formulations Abandoned AU6832394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6244793A 1993-05-15 1993-05-15
US062447 1993-05-15
PCT/US1994/005316 WO1994026110A1 (en) 1993-05-15 1994-05-13 Stable quinolone and naphthyridine premix formulations

Publications (1)

Publication Number Publication Date
AU6832394A true AU6832394A (en) 1994-12-12

Family

ID=22042549

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68323/94A Abandoned AU6832394A (en) 1993-05-15 1994-05-13 Stable quinolone and naphthyridine premix formulations

Country Status (4)

Country Link
AU (1) AU6832394A (en)
IL (1) IL109626A0 (en)
WO (1) WO1994026110A1 (en)
ZA (1) ZA943317B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (en) 1997-12-05 1999-06-10 Upjohn Co QUINOLON MAGNESIUM ANTIBIOTIC COMPOUNDS
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
GR1008168B (en) * 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831514A1 (en) * 1988-09-16 1990-03-22 Bayer Ag PH NEUTRAL WAESSED SOLUTIONS OF CHINOLO CARBON ACIDS
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids

Also Published As

Publication number Publication date
ZA943317B (en) 1995-01-23
IL109626A0 (en) 1994-08-26
WO1994026110A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
AU3265695A (en) Novel naphthyridine derivative and medicinal composition thereof
AU4426497A (en) Formulations and methods for providing prolonged local anesthesia
EP0721328A4 (en) Camptothecin formulations
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU1959992A (en) 3-aryl-4-hydroxy-3-dihydrofuranone and 3-aryl-4-hydroxy- 3-dihydrothiophenone derivatives
AU5494294A (en) Hop extract and use thereof
AU4074597A (en) Maleimide containing formulations and uses therefor
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
IL131201A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
AU7328996A (en) Injectable quinolone formulations
AU6959694A (en) Antineoplastic compositions and methods of use
ZA9410235B (en) Slow-release insect-repellent formulations and uses
AU5803494A (en) Glass ionomer cement compositions and restorations
AU1714792A (en) Glass composition and use
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
AU6832394A (en) Stable quinolone and naphthyridine premix formulations
AU7235394A (en) Stabilized formulation
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU1106392A (en) Composition and use
AU3598493A (en) Shampoo premix compositions
AU1965192A (en) Color-developing compositions and their use
AU6842194A (en) Substituted quinoline compounds and their use as safeners
AU5417394A (en) Plug-in sleeve joint